Spleen-preserving splenic hilar lymphadenectomy at the time of gastrectomy for cancer: Technical feasibility and early results

Journal of Surgical Oncology

Volumn 79, Issue 1, 2002, Pages 73-76

  Schwarz, R E ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTOMOSIS LEAKAGE; ARTICLE; CANCER RECURRENCE; CANCER STAGING; GASTRECTOMY; LYMPHADENECTOMY; MORBIDITY; MORTALITY; OPERATION DURATION; PARAAORTIC LYMPH NODE; POSTGASTRECTOMY SYNDROME; PRIORITY JOURNAL; SPLENECTOMY; STOMACH CANCER; STOMACH EMPTYING; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND INFECTION;

ADENOCARCINOMA; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; SPLEEN; STOMACH NEOPLASMS;

EID: 0036144094     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10036     Document Type: Article

References (36)

1. Extended lymphnode dissection for gastric cancer
2. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial
3. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial
4. Surgical management of gastric cancer: The Western experience
5. Surgical treatment of gastric cancer. Proximal, mid, and distal stomach
6. Morbidity and mortality after D2 gastrectomy for gastric cancer: Results of the Italian Gastric Cancer Study Group prospective multicenter surgical study
7. Splenectomy for treatment of gastric cancer: Japanese experience
8. Pancreas-preserving total gastrectomy for proximal gastric cancer
9. Total gastrectomy with dissection of lymph nodes along the splenic artery: A pancreas-preserving method
10. Results of subtotal gastrectomy with complete dissection of the N2 lymph nodes preserving the spleen and pancreas in surgery for gastric cancer
11. Spleen- and pancreas-preserving total gastrectomy with superextended lymphadenectomy including dissection of the para-aortic lymph nodes for gastric cancer
12. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma
13. Does concurrent splenectomy at colorectal cancer resection influence survival?
14. Risks of synchronous gastrointestinal or biliary surgery with splenectomy for hematologic disease
15. Surgery for stomach cancer in a defined Swedish population: Current practices and operative results
16. Critical evaluation of prophylactic splenectomy in total gastrectomy for the stomach cancer
17. Evaluation of splenectomy in total gastrectomy for gastric cancer
18. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors
19. Preservation of the spleen improves survival after radical surgery for gastric cancer
20. Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on longterm survival
21. Influence of splenectomy on survival rate of patients with colorectal cancer
22. The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma
23. Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer
24. End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma
25. Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma
26. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer
27. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses
28. Effect of splenectomy and immunotherapy on advanced gastric cancer associated with total gastrectomy
29. The role of the spleen in immunosuppression and the effects of splenectomy on prognosis in gastric cancer patients
30. Splenectomy in cancer gastrectomy: Recommendation of spleen-preserving for early stages
31. Effect of splenectomy in tumor-bearing mice and gastric cancer patients
32. Monitoring immuno-competent cells in the peripheral blood of stomach cancer patients after splenectomy and gastrectomy
33. Effects of splenectomy on the development of tumor-specific immunity
34. The negative effect of splenectomy on the prognosis of gastric cancer
35. Risk factors for complications following resection of large gastric cancer
36. Evaluation of splenectomy and possible metastasis from gastric cancer, with reference to nonspecific immunological parameters and postoperative survival